Chewy, Inc. announced the appointment of Deborah Ellinger to its Board of Directors, increasing the board size from twelve to thirteen members. Ellinger, an experienced executive and board member, has extensive expertise in consumer products and pet-related industries. She is currently a Senior Advisor at Boston Consulting Group (BCG), where she works with private equity clients in consumer and retail investments.

Her career includes leadership roles as CEO or President at multiple private-equity-backed companies, including Ideal Image, The Princeton Review, Restoration Hardware, and Wellness Pet Food. She also held senior executive positions at CVS Pharmacy, Staples, and BCG, and began her career in banking at Mellon Financial Corporation.

Ellinger has served on various public and private boards, including Tupperware, iRobot, Covetrus, Sealy, and Interpublic, among others. She holds a Bachelor of Arts and Master of Arts from the University of Cambridge, UK, and is a non-practicing Barrister-at-Law.

The Board determined that Ellinger qualifies as an independent director under SEC and NYSE regulations. She will serve as a Class II director with a term expiring in 2027 and will receive Chewy’s standard annual compensation for non-affiliated directors. Additionally, she has entered into an indemnification agreement with the company similar to those of other directors.

There are no related-party transactions requiring disclosure, and her appointment was not based on any prior arrangement or understanding with other individuals.

This appointment is effective as of February 21, 2025, and was officially signed by Da-Wai Hu, General Counsel and Secretary of Chewy, Inc.